Evidence map›Paper›PMID 34613791›Full record

ArticleJournal of virology2022

Molecular Coevolution of Nuclear and Nucleolar Localization Signals inside the Basic Domain of HIV-1 Tat.

Margarita A Kurnaeva, Arthur O Zalevsky, Eugene A Arifulin, Olga M Lisitsyna, Anna V Tvorogova, Maria Y Shubina, Gleb P Bourenkov, Maria A Tikhomirova, Daria M Potashnikova, Anastasia I Kachalova and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Margarita A Kurnaeva *Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, Russia.
Arthur O Zalevsky *Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, Russia.
Eugene A Arifulin *Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
Olga M LisitsynaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
Anna V TvorogovaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
Maria Y ShubinaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
Gleb P BourenkovEuropean Molecular Biology Laboratory, Hamburg, Germany.
Maria A TikhomirovaFaculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, Russia.
Daria M PotashnikovaDepartment of Cell Biology and Histology, Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia.
Anastasia I KachalovaDepartment of Cell Biology and Histology, Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia.
Yana R MusinovaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
Andrey V GolovinFaculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, Russia.
Yegor S VassetzkyKoltzov Institute of Developmental Biology, Russian Academy of Sciences, Moscow, Russia.ORCID 0000-0003-3101-7043
Eugene V ShevalBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.ORCID 0000-0003-1687-1321
Lomonosov Moscow State University · RUCentre National de la Recherche Scientifique · FREuropean Molecular Biology Laboratory · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During evolution, viruses had to adapt to an increasingly complex environment of eukaryotic cells. Viral proteins that need to enter the cell nucleus or associate with nucleoli possess nuclear localization signals (NLSs) and nucleolar localization signals (NoLSs) for nuclear and nucleolar accumulation, respectively. As viral proteins are relatively small, acquisition of novel sequences seems to be a more complicated task for viruses than for eukaryotes. Here, we carried out a comprehensive analysis of the basic domain (BD) of HIV-1 Tat to show how viral proteins might evolve with NLSs and NoLSs without an increase in protein size. The HIV-1 Tat BD is involved in several functions, the most important being the transactivation of viral transcription. The BD also functions as an NLS, although it is substantially longer than a typical NLS. It seems that different regions in the BD could function as NLSs due to its enrichment with positively charged amino acids. Additionally, the high positive net charge inevitably causes the BD to function as an NoLS through a charge-specific mechanism. The integration of NLSs and NoLSs into functional domains enriched with positively charged amino acids might be a mechanism that allows the condensation of different functional sequences in small protein regions and, as a result, reduces protein size, influencing the origin and evolution of NLSs and NoLSs in viruses.

Indexed as

Gene Expression Regulation, ViralNuclear Localization SignalsProtein Interaction Domains and MotifsAmino Acid SequenceBinding SitesCell NucleolusCell NucleusConsensus SequenceEvolution, MolecularHIV-1HIV InfectionsHost-Pathogen InteractionsModels, MolecularProtein BindingProtein TransportStructure-Activity RelationshipNuclear Localization Signalstat Gene Products, Human Immunodeficiency VirusViral ProteinsevolutionHIV-1 Tatnuclear localization signal (NLS)nucleolar localization signal (NoLS)viruses

Identifiers

PMID34613791
PMCPMC8754208
OpenAlexW3203289585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.